Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma
Findings in 42 patients followed for 1–16 years

References

• Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Karini-emi AL, Keski-Oja J, Saarialho-Kere UK. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melano-mas. Br J Cancer 1999; 80 (5–6): 733–43.
   Google Scholar
• Albini A, Melchiori A, Santi L, Liotta L A, Brown P D, Stetler-Stevenson W G. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991; 83(11): 775–9.
   Google Scholar
• Benassi M S, Gamberi G, Magagnoli G, Molendini L, Ragazzini P, Merli M, Chiesa F, Balladelli A, Manfrini M, Bertoni F, Mercuri M, Picci P. Metalloproteinase expression and prognosis in soft tissue sarcomas. Ann Oncol 2001; 12 (1): 75–80.
   PubMed Web of Science ®Google Scholar
• Benassi M S, Magagnoli G, Ponticelli F, Pazzaglia L, Zanella L, Gamberi G, Ragazzini P, Ferrari C, Mercuri M, Picci P. Tissue and serum loss of metalloproteinase inhibitors in high grade soft tissue sarcomas. Histol His-topathol 2003; 18 (4): 1035–40.
   PubMed Web of Science ®Google Scholar
• Berend KR, Toth A P, Harrelson J M, Layfield L J, Hey LA, Scully S P. Association between ratio of matrix metallo-proteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chon-drosarcoma. J Bone Joint Surg (Am) 1998; 80 (1): 11–7.
   PubMed Web of Science ®Google Scholar
• Davies B, Miles D W, Happerfield L C, Naylor M S, Bobrow L G, Rubens R D, Balkwill F R. Activity of type IV col-lagenases in benign and malignant breast disease. Br J Cancer 1993a; 67 (5): 1126–31.
   PubMed Web of Science ®Google Scholar
• Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993b; 53 (22): 5365–9.
   PubMed Web of Science ®Google Scholar
• Gomez D E, Alonso D F, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74: 111–22.
   PubMed Web of Science ®Google Scholar
• Guedez L, Stetler-Stevenson W G, Wolff L, Wang J, Fuku-shima P, Mansoor A, Stetler-Stevenson M. In vitro sup-pression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 1998; 102 (11): 2002–10.
   PubMed Web of Science ®Google Scholar
• Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metal-loproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992; 298 (1): 29–32.
   Google Scholar
• Himelstein B P, Asada N, Carlton M R, Collins M H. Matrix metalloproteinase-9 (M MP-9) expression in childhood osseous osteosarcoma. Med Pediatr Oncol 1998; 31 (6): 471–4.
   Google Scholar
• Kahari V M, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999; 31(1): 34–45.
   PubMed Web of Science ®Google Scholar
• Link M P, Goorin AM, Miser A W, Green A A, Pratt C B, Belasco J B, Pritchard J, Malpas J S, Baker AR, Kirkpat-rick J A, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 314 (25): 1600–6.
   Google Scholar
• Liotta LA, Steeg P S, Stetler-Stevenson W G. Cancer metas-tasis and angiogenesis: an imbalance of positive and nega-tive regulation. Cell 1991; 64 (2): 327–36.
   Google Scholar
• MacDougall J R, Bani M R, Lin Y, Rak J, Kerbel R S. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridiza-tion with early stage melanoma cells. Cancer Res 1995; 55 (18): 4174–81.
   PubMed Web of Science ®Google Scholar
• Nelson A R, Fingleton B, Rothenberg M L, Matrisian L M. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18 (5): 1135–49.
   PubMed Web of Science ®Google Scholar
• Ray J M, Stetler-Stevenson W G. The role of matrix metallo-proteases and their inhibitors in tumour invasion, metasta-sis and angiogenesis. Eur Respir J 1994; 7 (11): 2062–72.
   PubMed Web of Science ®Google Scholar
• Reich R, Thompson E W, Iwamoto Y, Martin G R, Deason J R, Fuller G C, Miskin R. Effects of inhibitors of plas-minogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 1988; 48 (12): 3307–12.
   PubMed Web of Science ®Google Scholar
• Saito T, Oda Y, Sakamoto A, Tamiya S, Iwamoto Y, Tsuney-oshi M, Matrix metalloproteinase-2 expression correlates with morphological and immunohistochemical epithelial characteristics in synovial sarcoma. Histopathology 2002; 40: 279–85.
   PubMed Web of Science ®Google Scholar
• Serra M, Scotlandi K, Reverter-Branchat G, Ferrari S, Manara M C, Benini S, Incaprera M, Bertoni F, Mercuri M, Briccoli A, Bacci G, Picci P. Value of P-glycopro-tein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities. J Clin Oncol 2003; 21(3): 536–42.
   Google Scholar
• Sier C F, Kubben F J, Ganesh S, Heerding MM, Griffioen G, Hanemaaijer R, van Krieken J H, Lamers C B, Verspaget H W. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996; 74 (3): 413–7.
   PubMed Web of Science ®Google Scholar
• Soderstrom M, Aro H T, Ahonen M, Johansson N, Aho A, Ekfors T, Bohling T, Kahari V M, Vuorio E. Expression of matrix metalloproteinases and tissue inhibitors of metal-loproteinases in human chondrosarcomas. APMIS 2001; 109: 305–15.
   PubMed Web of Science ®Google Scholar
• Soloway PD, Alexander CM, Werb Z, Jaenisch R. Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host. Oncogene 1996; 13 (11): 2307–14.
   PubMed Web of Science ®Google Scholar
• Stearns M E, Wang M. Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 1993; 53 (4): 878–83.
   PubMed Web of Science ®Google Scholar
• Talvensaari-Mattila A, Paakko P, Hoyhtya M, Blanco-Sequeiros G, Turpeenniemi-Hujanen T. Matrix metal-loproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma. Cancer 1998; 83 (6): 1153–62.
   Google Scholar
• Tsuchiya Y, Endo Y, Sato H, Okada Y, Mai M, Sasaki T, Seiki M. Expression of type-IV collagenases in human tumor cell lines that can form liver colonies in chick embryos. Int J Cancer 1994; 56(1): 46–51.
   Google Scholar
• Vaisanen A, Tuominen H, Kallioinen M, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 1996; 180 (3): 283–9.
   Google Scholar